Top

Published in:

Open Access 01-12-2007 | Original Article

Improving diagnosis and treatment of osteoporosis: evaluation of a clinical pathway for low trauma fractures

Authors: L. L. Laslett, J. N. Whitham, C. Gibb, T. K. Gill, J. A. Pink, J. D. McNeil, on behalf of the Osteoporosis SA Refracture Prevention Pathway Steering Committee

Published in: Archives of Osteoporosis | Issue 1-2/2007

Abstract

Summary

Diagnosis and treatment of osteoporosis in hospitals is poor. We compared patient outcomes before and after implementation of a clinical protocol for low-trauma fractures. Patients in the pathway were more likely to receive information about osteoporosis or osteoporosis medications. Therefore our clinical pathway is effective in improving osteoporosis information and treatment.

Introduction

Effective therapies for reducing fracture risk are available, yet under-utilised in hospital settings. We aimed to increase rates of initiation of osteoporosis investigations, pharmacological treatment, treatment continuation, and follow-up general practitioner (GP) visits.

Methods

Comparison of patient outcomes before and after implementation of a clinical pathway in patients admitted for low-trauma fractures to the Department of Orthopaedics and Trauma at The Queen Elizabeth Hospital, Adelaide.

Results

Patients enrolled in the osteoporosis clinical pathway (n = 28) were more likely than patients receiving usual care (n = 28) to have received information about (54% vs. 29%; p < 0.05), or a prescription for osteoporosis medication (53% vs. 25%, p < 0.05). Differences in proportions of patients visiting their GP post fracture and in osteoporosis investigations suggested or undertaken were not significant. At the later audit, the high proportion of patients receiving information about osteoporosis medication had been maintained (51%). Prescription of osteoporosis medications increased to 83% (p < 0.01), and more patients saw their GP post fracture (87%; p < 0.01). High rates of medication adherence were reported in patients in all groups receiving prescriptions.

Conclusion

A clinical pathway for improving hospital management of osteoporosis is effective in improving education about, prescription for, and uptake of osteoporosis medications.

Available only for authorised users

Nguyen TV, Center JR, Eisman JA (2004) Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 180:S18–S22PubMed

Jones G, Nguyen T, Sambrook PN et al (1994) Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 4:277–282PubMedCrossRef

March LM, Cameron ID, Cumming RG et al (2000) Mortality and morbidity after hip fracture: can evidence based clinical pathways make a difference? J Rheumatol 27:2227–2231PubMed

Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures. BMJ 307:1248–1250PubMedCrossRef

Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. Jama 285:320–323PubMedCrossRef

Johansson C, Mellstrom D (1996) An earlier fracture as a risk factor for new fracture and its association with smoking and menopausal age in women. Maturitas 24:97–106PubMedCrossRef

Haentjens P, Autier P, Collins J et al (2003) Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am 85-A:1936–1943PubMed

The Burden of Brittle Bones: Costing Osteoporosis in Australia. Canberra, ACT: Access Economics Pty Ltd.; 2001

Cranney A, Guyatt G, Griffith L et al (2002) Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570–578PubMedCrossRef

10.

Hosking D, Adami S, Felsenberg D et al (2003) Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled study. Curr Med Res Opin 19:383–394PubMedCrossRef

11.

McClung MR, Geusens P, Miller PD et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333–340PubMedCrossRef

12.

Phillipov G, Phillips PJ, Leach G et al (1998) Public perceptions and self-reported prevalence of osteoporosis in South Australia. Osteoporos Int 8:552–556PubMedCrossRef

13.

Wong PK, Spencer DG, McElduff P et al (2003) Secondary screening for osteoporosis in patients admitted with minimal-trauma fracture to a major teaching hospital. Intern Med J 33:505–510PubMedCrossRef

14.

Smith MD, Ross W, Ahern MJ (2001) Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J Rheumatol 28:2504–2508PubMed

15.

Majumdar SR, Rowe BH, Folk D et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366–373PubMed

16.

Sidwell AI, Wilkinson TJ, Hanger HC (2004) Secondary prevention of fractures in older people: evaluation of a protocol for the investigation and treatment of osteoporosis. Intern Med J 34:129–132PubMedCrossRef

17.

Myers TA, Briffa NK (2003) Secondary and tertiary prevention in the management of low-trauma fracture. Aust J Physiother 49:25–29PubMed

18.

Seagger R, Howell J, David H et al (2004) Prevention of secondary osteoporotic fractures-why are we ignoring the evidence? Injury 35:986–988PubMedCrossRef

19.

Kamel HK, Hussain MS, Tariq S et al (2000) Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109:326–328PubMedCrossRef

20.

Jones G, Warr S, Francis E et al (2005) The effect of a fracture protocol on hospital prescriptions after minimal trauma fractured neck of the femur: a retrospective audit. Osteoporos Int 16:1277–1280PubMedCrossRef

21.

Rose S, Maffulli N (1999) Hip fractures. An epidemiological review. Bull Hosp Jt Dis 58:197–201PubMed

22.

Glover J, Harris K, Tennant S (1999) A social health atlas of South Australia, 2nd edn. Public Health Information Development Unit, the University of Adelaide

Title: Improving diagnosis and treatment of osteoporosis: evaluation of a clinical pathway for low trauma fractures
Authors: L. L. Laslett
J. N. Whitham
C. Gibb
T. K. Gill
J. A. Pink
J. D. McNeil
on behalf of the Osteoporosis SA Refracture Prevention Pathway Steering Committee
Publication date: 01-12-2007
Publisher: Springer-Verlag
Published in: Archives of Osteoporosis / Issue 1-2/2007
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-007-0010-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Improving diagnosis and treatment of osteoporosis: evaluation of a clinical pathway for low trauma fractures

Abstract

Summary

Introduction

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1-2/2007

High prevalence of fractures in Brazilian patients with inflammatory bowel disease: lack of association with bone mass density and quantitative ultrasound measurements

Changing epidemiology of osteoporotic hip fracture rates in Hong Kong

Osteoporosis among Ethiopian immigrant women: a risk analysis

Bone growth patterns in Chinese children and adolescents: a 6-year follow-up study provides evidence for sexual dimorphism and tracking

Body mass index, percent body fat, and bone mass in a cohort of Chinese twins aged 6 to 18 years